Vectron Biosolutions was founded in 2008 as a result of more than 15 years of research in Professor Svein Valla's research group at the Department of Biotechnology at the University of Science and Technology (NTNU) in Trondheim, Norway. Professor Svein Valla is a world-leading expert on gene expression in bacteria and vector technology with more than 100 publications in peer-reviewed scientific journals. His research has resulted in a novel technology platform for production of recombinant proteins that can be used for higher protein production levels at lower costs and increased solubility. This innovative technology comprises Vectron's core technology.
Supplier of superior technology and solutions
Through a combination of experienced life science researchers, state-of-the-art laboratory facilities, a proprietary technology platform and competent management, Vectron Biosolutions AS supplies the life sciences with superior technology and solutions. The company focuses on developing broad-host-range vector technology, especially expression vectors for industrial level production of recombinant proteins.